Nalluru Murthy is listed as an executive officer, director, and promoter on 4 SEC Form D filings by 2 issuers between Nov 2018 and Aug 2022: NeuTrace, Inc. (Longwood, FL — other health care — 2020–2022; $4.8M reported sold to 74 investors) and NeuCures, Inc. (Marina Del Rey, CA — other health care — 2018; $485K reported sold to 7 investors).
What this means 2 separate companies raised money with this person listed as executive officer, director, and promoter, over about 4 years. Across those companies the filings report $5.28M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 4 public filings for Nalluru Murthy and found 9 differences: Bankruptcy case: House2home, Inc., Reorganized v. Mendu Schiffer; 16% of the money raised went to insiders; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.